Ionic Capital Management’s GeneDx Holdings WGS Stock Holding History

Ionic Capital Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-77	Closed	-$1.7K	–	447
2022 Q3	$2K	Buy	+77	New	+$3.52K	﹤0.01%	466

Other funds holding WGS

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Ionic Capital Management's WGS Position: Q4 2022 in Review

Ionic Capital Management sold out of GeneDx Holdings (WGS) in Q4 2022, closing a stake of 77 shares — an estimated $1.7K sold.

Ionic Capital Management first reported a position in WGS in Q3 2022 and held it in 1 quarter. The position peaked at $2K in Q3 2022. 86 funds tracked by Wall St. Rank hold WGS as of Q4 2022.

Ionic Capital Management reported no remaining GeneDx Holdings position as of Q4 2022 after selling out during the quarter.
Ionic Capital Management sold 77 GeneDx Holdings shares in Q4 2022, an estimated $1.7K.
Ionic Capital Management first reported a position in GeneDx Holdings in Q3 2022 and held it in 1 quarter.
Ionic Capital Management's GeneDx Holdings position peaked at $2K in Q3 2022.
86 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2022.

Based on Ionic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.